Diethylstilbestrol: Potential health risks for women exposed in utero and their offspring.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  JAAPA : official journal of the American Academy of Physician Assistants

• Publication date

  2017-02-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1097/01.JAA.0000511800.91372.34PMID 28098674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pediatric forearm injury after a fall

  2017cited by this paper
• Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters

  2014cited by this paper
• Adverse health outcomes in women exposed in utero to diethylstilbestrol.

  2011cited by this paper
• Cancer risk in DES daughters

  2010cited by this paper
• Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES).

  2010cited by this paper
• Draft Report from the ICD-2 Research Program Task Force

  2009cited by this paper
• What are contraindications to IUDs

  2006cited by this paper
• Prenatal Diethylstilbestrol Exposure and Risk of Breast Cancer

  2006cited by this paper
• Age at natural menopause in women exposed to diethylstilbestrol in utero.

  2006cited by this paper
• Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES).

  2006cited by this paper
• Clinical inquiries. What are contraindications to IUDs?

  2006cited by this paper
• Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals.

  2003cited by this paper
• Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study.

  2002cited by this paper
• Late lessons from early warnings : the precautionary principle 1896 – 2000 8 . The DES story : long-term consequences of prenatal exposure

  2002cited by this paper
• A focus group study of DES daughters: implications for health care providers

  2000cited by this paper
• Diethylstilbestrol Revisited: A Review of the Long-Term Health Effects

  1995cited by this paper

• Trisubstituted Alkenes as Valuable Building Blocks

  2025cites this paper
• The Association between Maternal Endocrine-Disrupting Chemical Exposure during Pregnancy and the Incidence of Male Urogenital Defects: A Systematic Review and Meta-Analysis

  2024cites this paper
• Primary vaginal cancer after hysterectomy for benign conditions: a systematic review of the literature

  2024cites this paper
• Environmental estrogens shape disease susceptibility.

  2023cites this paper
• Computational Studies, GERS, Photovoltaic Modelling and Molecular Docking Studies of Diethylstilbestrol and Its Methyl Ether

  2022cites this paper
• The Role of Maternal and Environmental Factors During Pregnancy on the Risk of Hypospadias Occurrence

  2022cites this paper
• Endocrine disrupting chemicals impact on ovarian aging: Evidence from epidemiological and experimental evidence.

  2022cites this paper
• Are the Effects of DES Over? A Tragic Lesson from the Past

  2021cites this paper
• Diethylstilbestrol Modifies the Structure of Model Membranes and Is Localized Close to the First Carbons of the Fatty Acyl Chains

  2021cites this paper
• Overview of the Mechanisms of Action of Selected Bisphenols and Perfluoroalkyl Chemicals on the Male Reproductive Axes

  2021cites this paper
• In utero exposure to endocrine-disrupting chemicals, maternal factors and alterations in the epigenetic landscape underlying later-life health effects.

  2021cites this paper
• Endokrin Bozucuların Üreme ve Gelişim Toksisitesi Üzerine Etkileri

  2021cites this paper
• Safeguarding Female Reproductive Health Against Endocrine Disrupting Chemicals—The FREIA Project

  2020cites this paper
• Chemical Castration as an Evolving Concept: Is It a Possible Solution for Sexual Offences?

  2020cites this paper
• Endocrine-Disrupting Chemicals’ (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1

  2020cites this paper
• The Relationship between Estrogen-Related Signaling and Human Papillomavirus Positive Cancers

  2020cites this paper
• Médicaments et grossesse, impacts fœtaux et néonatals

  2020cites this paper
• Transplacental exposure to carcinogens and risks to children: evidence from biomarker studies and the utility of omic profiling

  2019cites this paper
• Occupational exposure to endocrine-disrupting chemicals and other parental risk factors in hypospadias and cryptorchidism development: a case-control study.

  2019cites this paper
• Understanding Epigenetic Effects of Endocrine Disrupting Chemicals: From Mechanisms to Novel Test Methods.

  2018cites this paper
• [Endocrine disrupters: Towards an unsatisfying regulation].

  2018cites this paper
• Case Report: Management of isolated Para-aortic lymph nodal recurrence after primary chemo-radiotherapy treatment for vaginal clear cell carcinoma

  year unknowncites this paper